Today, the standard treatment for spinal pathologies, arthrodesis, faces two important limitations:
1) most implants prevent precise execution of spinal surgery
2) the latter is insufficiently organized, which can lead to inaccurate interventions and risky and costly reoperations

In the arthrodesis market, estimated at 3 billion dollars¹, SMAIO is one of the few players able to overcome these two limitations thanks to an approach that has been designed from the outset as global and integrated, providing the surgeon with a complete surgical strategy for a lasting result. This innovative approach is embodied in SMAIO's i-Kontrol platform, which is based on three pillars: precise planning, customized execution and long-term patient follow-up.
----------------------
1 The Millennium Research Group